Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction

Chul Min Ahn, Soon Jun Hong, Seung Cheol Choi, Jae Hyung Park, Jae Sang Kim, Do-Sun Lim

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The effects of red ginseng extract on circulating angiogenic cell mobilization and improvement of microvascular integrity were evaluated in ST-elevation acute myocardial infarction (AMI) patients during 8-month follow-up. AMI patients (n = 50) were randomly assigned to the red ginseng group (3 g/day, n = 25) or the placebo group (n = 25) after coronary stenting. Coronary flow reserve (CFR) was measured at baseline and at 8 months with an intracoronary Doppler wire. Serial changes in the absolute numbers of circulating angiogenic cells such as CD34+, CXCR4+, CD117+, CD133+ and C-met+ were measured at baseline, 1 day, 5 days and at 8 months. CFR were similar between the two groups at baseline, and CFR was significantly higher in the red ginseng group than in the placebo group (2.80 ± 0.91 and 2.56 ± 0.77, p < 0.05, respectively) after 8 months of red ginseng administration. The absolute numbers of circulating CD34+, CXCR4+ and CD117+ cells were significantly higher in the red ginseng group at 1 and 5 days after stenting. Significant positive correlations were found between the numbers of circulating angiogenic cells at day 1 and the changes from baseline in CFR for CD34+, CXCR4+, CD117+ and C-met+ cells. Red ginseng extract increased CD34+, CXCR4+ and CD117+ circulating angiogenic cell mobilization and decreased inflammation in AMI patients, thereby improving CFR during the 8-month follow-up.

Original languageEnglish
Pages (from-to)239-249
Number of pages11
JournalPhytotherapy Research
Volume25
Issue number2
DOIs
Publication statusPublished - 2011 Feb 1

Fingerprint

Panax
Myocardial Infarction
Placebos
ST Elevation Myocardial Infarction
Inflammation

Keywords

  • acute myocardial infarction
  • coronary flow reserve
  • red ginseng extract
  • stem cell

ASJC Scopus subject areas

  • Pharmacology

Cite this

Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction. / Ahn, Chul Min; Hong, Soon Jun; Choi, Seung Cheol; Park, Jae Hyung; Kim, Jae Sang; Lim, Do-Sun.

In: Phytotherapy Research, Vol. 25, No. 2, 01.02.2011, p. 239-249.

Research output: Contribution to journalArticle

@article{bdb1e0cbc61f49c39473dfbad5c2ab36,
title = "Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction",
abstract = "The effects of red ginseng extract on circulating angiogenic cell mobilization and improvement of microvascular integrity were evaluated in ST-elevation acute myocardial infarction (AMI) patients during 8-month follow-up. AMI patients (n = 50) were randomly assigned to the red ginseng group (3 g/day, n = 25) or the placebo group (n = 25) after coronary stenting. Coronary flow reserve (CFR) was measured at baseline and at 8 months with an intracoronary Doppler wire. Serial changes in the absolute numbers of circulating angiogenic cells such as CD34+, CXCR4+, CD117+, CD133+ and C-met+ were measured at baseline, 1 day, 5 days and at 8 months. CFR were similar between the two groups at baseline, and CFR was significantly higher in the red ginseng group than in the placebo group (2.80 ± 0.91 and 2.56 ± 0.77, p < 0.05, respectively) after 8 months of red ginseng administration. The absolute numbers of circulating CD34+, CXCR4+ and CD117+ cells were significantly higher in the red ginseng group at 1 and 5 days after stenting. Significant positive correlations were found between the numbers of circulating angiogenic cells at day 1 and the changes from baseline in CFR for CD34+, CXCR4+, CD117+ and C-met+ cells. Red ginseng extract increased CD34+, CXCR4+ and CD117+ circulating angiogenic cell mobilization and decreased inflammation in AMI patients, thereby improving CFR during the 8-month follow-up.",
keywords = "acute myocardial infarction, coronary flow reserve, red ginseng extract, stem cell",
author = "Ahn, {Chul Min} and Hong, {Soon Jun} and Choi, {Seung Cheol} and Park, {Jae Hyung} and Kim, {Jae Sang} and Do-Sun Lim",
year = "2011",
month = "2",
day = "1",
doi = "10.1002/ptr.3250",
language = "English",
volume = "25",
pages = "239--249",
journal = "Phytotherapy Research",
issn = "0951-418X",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Red ginseng extract improves coronary flow reserve and increases absolute numbers of various circulating angiogenic cells in patients with first ST-segment elevation acute myocardial infarction

AU - Ahn, Chul Min

AU - Hong, Soon Jun

AU - Choi, Seung Cheol

AU - Park, Jae Hyung

AU - Kim, Jae Sang

AU - Lim, Do-Sun

PY - 2011/2/1

Y1 - 2011/2/1

N2 - The effects of red ginseng extract on circulating angiogenic cell mobilization and improvement of microvascular integrity were evaluated in ST-elevation acute myocardial infarction (AMI) patients during 8-month follow-up. AMI patients (n = 50) were randomly assigned to the red ginseng group (3 g/day, n = 25) or the placebo group (n = 25) after coronary stenting. Coronary flow reserve (CFR) was measured at baseline and at 8 months with an intracoronary Doppler wire. Serial changes in the absolute numbers of circulating angiogenic cells such as CD34+, CXCR4+, CD117+, CD133+ and C-met+ were measured at baseline, 1 day, 5 days and at 8 months. CFR were similar between the two groups at baseline, and CFR was significantly higher in the red ginseng group than in the placebo group (2.80 ± 0.91 and 2.56 ± 0.77, p < 0.05, respectively) after 8 months of red ginseng administration. The absolute numbers of circulating CD34+, CXCR4+ and CD117+ cells were significantly higher in the red ginseng group at 1 and 5 days after stenting. Significant positive correlations were found between the numbers of circulating angiogenic cells at day 1 and the changes from baseline in CFR for CD34+, CXCR4+, CD117+ and C-met+ cells. Red ginseng extract increased CD34+, CXCR4+ and CD117+ circulating angiogenic cell mobilization and decreased inflammation in AMI patients, thereby improving CFR during the 8-month follow-up.

AB - The effects of red ginseng extract on circulating angiogenic cell mobilization and improvement of microvascular integrity were evaluated in ST-elevation acute myocardial infarction (AMI) patients during 8-month follow-up. AMI patients (n = 50) were randomly assigned to the red ginseng group (3 g/day, n = 25) or the placebo group (n = 25) after coronary stenting. Coronary flow reserve (CFR) was measured at baseline and at 8 months with an intracoronary Doppler wire. Serial changes in the absolute numbers of circulating angiogenic cells such as CD34+, CXCR4+, CD117+, CD133+ and C-met+ were measured at baseline, 1 day, 5 days and at 8 months. CFR were similar between the two groups at baseline, and CFR was significantly higher in the red ginseng group than in the placebo group (2.80 ± 0.91 and 2.56 ± 0.77, p < 0.05, respectively) after 8 months of red ginseng administration. The absolute numbers of circulating CD34+, CXCR4+ and CD117+ cells were significantly higher in the red ginseng group at 1 and 5 days after stenting. Significant positive correlations were found between the numbers of circulating angiogenic cells at day 1 and the changes from baseline in CFR for CD34+, CXCR4+, CD117+ and C-met+ cells. Red ginseng extract increased CD34+, CXCR4+ and CD117+ circulating angiogenic cell mobilization and decreased inflammation in AMI patients, thereby improving CFR during the 8-month follow-up.

KW - acute myocardial infarction

KW - coronary flow reserve

KW - red ginseng extract

KW - stem cell

UR - http://www.scopus.com/inward/record.url?scp=79551658049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551658049&partnerID=8YFLogxK

U2 - 10.1002/ptr.3250

DO - 10.1002/ptr.3250

M3 - Article

VL - 25

SP - 239

EP - 249

JO - Phytotherapy Research

JF - Phytotherapy Research

SN - 0951-418X

IS - 2

ER -